SRX Global adds minority equity stake in Onconetix
Bitget2026/09/24 16:30- SRX Global added an equity investment in Onconetix (Nasdaq: ONCO) as it repositions its portfolio.
- Update also covered liquidation of holdings in Vistagen Therapeutics (Nasdaq: VTGN) and Greenland Mines (Nasdaq: GRML).
- Onconetix has announced an agreement to acquire Realbotix, which develops robotic eyeball hardware integrated with an AI vision system.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
